Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations
NCT: NCT06013449 · NOT_YET_RECRUITING
Brief Summary
The objective of this study is to test the idea that Pulsed Electromagnetic Field (PEMF) therapy will serve as a safe therapeutic modality that can effectively be administered simultaneously with bladder instillations of a bupivacaine-heparin cocktail to improve the chronic pain and/or associated symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) patients. The study team will distribute the PEMF device to female adults with IC/BPS who have been prescribed bladder instillations of bupivacaine-heparin to see if PEMF therapy in conjunction with bladder instillations of heparin and bupivacaine may be more effective in reducing pain levels and symptomatology of IC/BPS than instillations alone.
Frequently Asked Questions
What is Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations?
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations is a clinical trial registered under NCT06013449. Current status: NOT_YET_RECRUITING.
What is the status of NCT06013449?
The current status of NCT06013449 (Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations) is: NOT_YET_RECRUITING.
When did Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations start?
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.